Navigation Links
Invest in a future without dementia
Date:6/18/2008

Alzheimer's Australia today, released a report 'Australian Dementia Research' that recommends annual funding for dementia research be increased three-fold to $36 million in response to the growing economic and social impact of the dementia epidemic.

Prepared by the Dementia Collaborative Research Centre at the University of NSW, the report concludes that current investment over the last six years in dementia research was about $13 million, 0.6% of the total direct costs of the condition. It recommends investment in dementia research should be maintained at 1.5% of the direct cost of dementia to keep pace with the increasing costs of treatment and care.

By 2030, the total cost to the health care system of dementia is projected to rise to $8.2 billion and the number of people with dementia to double to more than 460,000.

The report concludes that dementia research in Australia is significantly under funded in relation to other chronic diseases. According to 2003 figures, dementia funding is 50% of research funding for cancer, relative to the current disease burden and 30% of research funding for cardiovascular disease, relative to current direct cost of care.

Professor Henry Brodaty, one of the authors of the report, said, "Australian dementia researchers have an excellent track record not withstanding inadequate funding for dementia research."

"The recent initiatives taken by the Federal Government in establishing three Dementia Collaborative Research Centres and a program of dementia grants are encouraging. However, investment in dementia research falls short of what is needed if more effective medical interventions are to be provided to the ever increasing number of people at risk of dementia or with a diagnosis of dementia", he said.

"There is a strong case for dementia to be recognised by the National Health and Medical Research Council as a National Health Priority Area."

Glenn Rees, National Executive Director of Alzheimer's Australia said, "modelling done by Access Economics shows if the onset of Alzheimer's disease could be delayed by five years, it would result in a 50% reduction of new cases each year with a significant saving to the direct cost of dementia".

He said, "This emphasises the importance of research strategies directed to early diagnosis and identifying those at most risk of dementia. In this way Australians will have earlier access to medications currently being trialled that hold out the prospect of modifying the disease."

Projects like the CSIRO Australian Imaging Biomarker and Lifestyle Flagship Study of Ageing (AIBL) "are a strong indication of the potential of Australian research to make a significant contribution to global research in key areas such as early diagnosis and reducing the risk of dementia," he said.

"There is a window of opportunity if investment in research is increased. This will address the issues that the growing numbers of people with dementia will pose for the health system within 15 years".


'/>"/>

Contact: Kaylia Dunstan
61-407-232-212
Research Australia
Source:Eurekalert

Related medicine news :

1. Rutgers scientist receives prestigious Young Investigator Award
2. Singapore Is One of the Fastest Growing Bioclusters in Asia; Wave of Investments in Drug Discovery and Translational Research
3. CIT GAP Funds Invests in OTraces, Inc.
4. Cardiva Medical, Inc. to Present at the Investment In Innovation (In3) Medical Device Summit on June 18, 2008 in San Francisco, CA; Announces the Completion of Its Latest Phase in Its US Sales Force Expansion
5. Digirad Corporation to Present at CapStone Small-Cap Investor Conference
6. Winning Method - Effective Identification and Development of Clinical Investigators
7. Case Western Reserve and Penn State investigators inhibit corneal inflammation
8. LA BioMed investigator wins Distinguished Educator Award
9. New Jersey Coalition Calls for Investigation of Private Wells to Protect Families from PFOA in Drinking Water
10. Carriage Services Updates Company & Investment Profile
11. White Ribbon Alliance for Safe Motherhood Challenges World Economic Forum on Africa to Invest in Womens Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... Fresh Wave® IAQ today announced the launch ... for colleges and universities at the APPA 2017 Annual Conference and Exhibition ... tobacco smoke odors without the use of harsh chemicals, Fresh Wave IAQ Smoke Away ...
(Date:7/21/2017)... (PRWEB) , ... July 21, 2017 , ... The Margarian ... falsely advertising the contents of its ginger ale for allegedly containing no ginger. Dr. ... Dr. Pepper Snapple Group, Inc., plaintiff Gegham Margaryan alleges Canada Dry Ginger Ale claims ...
(Date:7/21/2017)... ... 21, 2017 , ... “Kids aren't born knowing how to regulate their emotions ... Tucker, Founder of St. Louis-based positive education company Generation Mindful. To help with that ... July 21st. , The kit uses colorful, engaging and educational illustrations and games ...
(Date:7/21/2017)... ... July 21, 2017 , ... ... ligament (ACL) offer patients improved quality of life five years after injury, according ... Annual Meeting in Toronto, Ontario, Canada. The study followed patients for five ...
(Date:7/20/2017)... Boston, MA (PRWEB) , ... July 20, 2017 ... ... aggressive form of blood and bone marrow cancer that progresses rapidly without treatment. ... often recommended to reduce the chance of reoccurrence and relapse. With such ...
Breaking Medicine News(10 mins):
(Date:7/13/2017)... 13, 2017  Centurion Medical Products, a leader in medical product ... fecal impaction removal device for hospice patient care. ... Centurion Medical Products ... Patient pain management and emotional comfort are part ... alleviate patient pain while preventing unneeded emergency department admission due to ...
(Date:7/11/2017)... IRVINE, Calif. , July 11, 2017 Zymo Research Corp., ... new service that can quantify biological aging in a precise manner using ... Dr. Steve Horvath , a professor of human genetics and biostatistics ... Fielding School of Public Health , Zymo Research,s proprietary DNAge ™ ... loci. ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology: